A systematic review and meta-analysis of exposure-response analysis of osimertinib in patients with non-small-cell lung cancer.
APA
Shao W, Yang J, et al. (2026). A systematic review and meta-analysis of exposure-response analysis of osimertinib in patients with non-small-cell lung cancer.. European journal of clinical pharmacology, 82(4). https://doi.org/10.1007/s00228-026-04013-x
MLA
Shao W, et al.. "A systematic review and meta-analysis of exposure-response analysis of osimertinib in patients with non-small-cell lung cancer.." European journal of clinical pharmacology, vol. 82, no. 4, 2026.
PMID
41917247
같은 제1저자의 인용 많은 논문 (5)
- Accurate diagnosis of non-small cell and small cell lung cancer by using machine learning models trained with physical science features extracted from pathological images.
- Clinical trials of bispecific antibody therapy for colorectal cancer: advanced and next steps.
- Targeted lipidomics meets transcriptomics: how cinobufagin rewires fatty acid, sphingolipid, and glycerophospholipid metabolism to combat hepatoma cell growth.
- Neural network-aided unsupervised input function estimation for dual-time-window PET Patlak analysis.
- Association between diffusion tensor imaging analysis along the perivascular space (DTI-ALPS)-based glial-lymphatic dysfunction and cognitive impairment in non-small cell lung cancer.